LLC;Calitor Sciences, LLC;Calitor Sciences;Sunshine Lake Pharma Co., Ltd
发明人:
Xi, Ning
申请号：
AU2012223639
公开号：
AU2012223639B2
申请日:
2012.02.21
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The present invention provides novel substituted quinoline compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
